Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for RBSH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2023 -5.61M
March 31, 2023 -5.657M
December 31, 2022 -5.237M
September 30, 2022 -5.887M
June 30, 2022 -6.203M
March 31, 2022 -4.838M
December 31, 2021 -5.022M
September 30, 2021 -5.32M
June 30, 2021 -11.95M
March 31, 2021 -29.34M
December 31, 2020 -12.50M
September 30, 2020 -7.213M
June 30, 2020 -9.889M
March 31, 2020 -8.72M
December 31, 2019 -8.723M
September 30, 2019 -8.434M
June 30, 2019 -8.855M
March 31, 2019 -8.017M
December 31, 2018 -8.267M
September 30, 2018 -10.79M
June 30, 2018 -8.17M
March 31, 2018 -8.958M
December 31, 2017 -8.848M
September 30, 2017 -6.035M
June 30, 2017 -4.433M
Date Value
March 31, 2017 -3.938M
December 31, 2016 -3.429M
September 30, 2016 -4.039M
June 30, 2016 -2.85M
March 31, 2016 -2.375M
December 31, 2015 -1.908M
September 30, 2015 -1.839M
June 30, 2015 -2.826M
March 31, 2015 -1.349M
December 31, 2014 0.097M
September 30, 2014 1.318M
June 30, 2014 2.834M
March 31, 2014 0.622M
December 31, 2013 1.26M
September 30, 2013 3.256M
June 30, 2013 -0.454M
March 31, 2013 0.286M
December 31, 2012 -0.728M
September 30, 2012 -0.5568M
June 30, 2012 0.9688M
March 31, 2012 1.639M
December 31, 2011 3.053M
September 30, 2011 4.452M
June 30, 2011 5.537M
March 31, 2011 4.799M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 1.307B
Alnylam Pharmaceuticals, Inc. 1.354B
Anika Therapeutics, Inc. 137.28M
Savara, Inc. 143.66M
Vericel Corp. 370.04M